Perfluoroheptanoic acid (375-85-9)
Publications
A high-throughput toxicity screen of 42 per- and polyfluoroalkyl substances (PFAS) and functional assessment of migration and gene expression in human placental trophoblast cells
Bevin E. Blake, Brittany P. Rickard, and Suzanne E. Fenton
DOI: https://doi.org/10.22427/NTP-DATA-025-00001-0001-000-9
DOI: https://doi.org/10.22427/NTP-DATA-025-00001-0001-000-9
Exposure to Select PFAS and PFAS Mixtures Alters Response to Platinum-Based Chemotherapy in Endometrial Cancer Cell Lines
Brittany P. Rickard, Marta Overchuk, Justin Tulino, Xianming Tan, Frances S. Ligler, Victoria L. Bae-Jump, Suzanne E. Fenton, and Imran Rizvi
DOI: https://doi.org/10.22427/NTP-DATA-500-009-001-000-5
DOI: https://doi.org/10.22427/NTP-DATA-500-009-001-000-5
Select Per- and Polyfluoroalkyl Substances (PFAS) Induce Resistance to Carboplatin in Ovarian Cancer Cell Lines
Brittany P. Rickard, Xianming Tan, Suzanne E. Fenton, and Imran Rizvi
International Journal of Molecular Sciences (2022), 23(9), 5176; DOI: https://doi.org/10.3390/ijms23095176
DOI: https://doi.org/10.22427/NTP-DATA-025-00001-0002-000-0
International Journal of Molecular Sciences (2022), 23(9), 5176; DOI: https://doi.org/10.3390/ijms23095176
DOI: https://doi.org/10.22427/NTP-DATA-025-00001-0002-000-0
Photodynamic Priming Overcomes Per- and Polyfluoroalkyl Substance (PFAS)-Induced Platinum Resistance in Ovarian Cancer
Brittany P Rickard, Xianming Tan, Suzanne E Fenton, Imran Rizvi
Study Data
Other NTP Studies
Evaluation (500-009-001-000-5) of the Effect of PFAS and PFAS Mixtures (335-67-1, 375-85-9, 2706-90-3) on Endometrial Cancer Cell Lines response to Platinum Based Chemotherapy
Supplemental Materials
- 10.10.2023 Supplemental Figures.docx (67 mB)
- CEBS Endometrial Cancer PFAS Chemotherapy Response Manuscript Environ Health.pzfx (3 mB)
- Environ Health Endometrial Cancer Manuscript SuppMat Data.xlsx (71 kB)
- PDT-analysis_20230113[21].html (988 kB)
- PDT-analysis_20230531ab[45].html (953 kB)
- PDT-analysis_20230531c[13].html (973 kB)
Figures
- Figure - CEBS Endometrial Cancer PFAS Chemotherapy Response Manuscript Environ Health.pzfx (3 mB)
- Figure - Environ Health Endometrial Cancer Manuscript Data.xlsx (126 kB)
- Figure 1 - 09182023.tif (18 mB)
- Figure 1 - CEBS Endometrial Cancer PFAS Chemotherapy Response Manuscript Environ Health.pzfx (3 mB)
- Figure 1 - Environ Health Endometrial Cancer Manuscript Data.xlsx (126 kB)
- Figure 2 - 09182023.tif (17 mB)
- Figure 2 - CEBS Endometrial Cancer PFAS Chemotherapy Response Manuscript Environ Health.pzfx (3 mB)
- Figure 2 - Environ Health Endometrial Cancer Manuscript Data.xlsx (126 kB)
- Figure 3 - 09182023.tif (19 mB)
- Figure 3 - CEBS Endometrial Cancer PFAS Chemotherapy Response Manuscript Environ Health.pzfx (3 mB)
- Figure 3 - Environ Health Endometrial Cancer Manuscript Data.xlsx (126 kB)
- Figure 4 - 10.10.2023.tif (30 mB)
- Figure 4 - CEBS Endometrial Cancer PFAS Chemotherapy Response Manuscript Environ Health.pzfx (3 mB)
- Figure 4 - Environ Health Endometrial Cancer Manuscript Data.xlsx (126 kB)
- Figure 5 - 07312023.tif (31 mB)
- Figure 5 - CEBS Endometrial Cancer PFAS Chemotherapy Response Manuscript Environ Health.pzfx (3 mB)
- Figure 5 - Environ Health Endometrial Cancer Manuscript Data.xlsx (126 kB)
- Figure 6 - 07312023.tif (31 mB)
- Figure 6 - CEBS Endometrial Cancer PFAS Chemotherapy Response Manuscript Environ Health.pzfx (3 mB)
- Figure 6 - Environ Health Endometrial Cancer Manuscript Data.xlsx (126 kB)